Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer’s disease.

There are safe and effective treatments for these common viruses. Why aren’t they used in mainstream, neurology?
J Alzheimers Dis. 2014;38(4):741-5. doi: 10.3233/JAD-130977.

Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer’s disease.

Abstract

HSV-1 infection of the central nervous system targets the same brain regions most affected in Alzheimer’s disease (AD) and could play a pathogenic role in AD. HSV-1 serum IgG titers were analyzed in patients with mild AD (n = 83) and healthy controls (HC, n = 51); results were correlated with cortical grey matter (GM) volumes as analyzed by MRI. Seroprevalence and antibody (Ab) titers were comparable between AD and HC; elevated Ab titers (>75th percentile) were nevertheless significantly more frequent in AD and were positively correlated with cortical bilateral temporal and orbitofrontal GM volumes. HSV-1-specific-Ab could possibly play a protective role in the early stages of AD.

KEYWORDS:

Alzheimer’s disease; HSV-1; humoral immunity; magnetic resonance imaging

PMID:

 

24072067

 

[PubMed – indexed for MEDLINE] 
Icon for IOS Press
Maurice Preter, MD

About Maurice Preter MD

Maurice Preter, MD is a European and U.S. educated psychiatrist, psychotherapist, psychopharmacologist, neurologist, and medical-legal expert in private practice in Manhattan. He is also the principal of Fifth Avenue Concierge Medicine, PLLC, a medical concierge service and health advisory for select individuals and families.
This entry was posted in Aging, China, dietary, epigenetics, Events, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology and tagged . Bookmark the permalink.